The H2020 Research and Innovation Programme project entitled "An integrated approach to dissect determinants, risk factors and pathways of ageing of the immune system" (Acronym: ImmunoAgeing) was positively evaluated by the European Commission in the course of the PHC-2014-Stage 2 call. The project will start on May 1, 2015 with a duration of 4 years. The Grubeck-Loebenstein group of the Institute for Biomedical Aging Research of the University of Innsbruck will be part of the consortium which consits of four partners from three countries (UK, Austria and Italy) with a proven expertise in immunology, clinical medicine, bioinformatics and statistics.